Mednax, Inc (NYSE:MD) reported earnings of $0.85 per share missing Walls Streets expectations.

ME Staff
-
0

Mednax, Inc (NYSE:MD) reported Q2 2017 earnings this Morning, coming in at $0.85 per share, missing Wall Street’s estimates of $0.87 per Share. Revenue for the quarter came in at $843.00 million missing the streets estimates of $849.49 million

Analyst Coverage For Mednax, Inc (NYSE:MD)
These are 1 Sell Rating, 8 Hold Ratings, 1 Buy Rating .
The current consensus rating for Mednax, Inc (NYSE:MD) is Hold (Score: 2.00) with a consensus target price of $64.50 , a potential (14.18% upside)

Recent Insider Trading for Mednax, Inc (NYSE:MD)

  • On 6/14/2017 Md Pascal J Goldschmidt, Director, sold 1,969 with an average share price of $57.57 per share and the total transaction amounting to $113,355.33.
  • On 6/1/2017 Joseph M Calabro, Insider, sold 23,327 with an average share price of $55.00 per share and the total transaction amounting to $1,282,985.00.
  • On 5/5/2017 Manuel Kadre, Director, bought 21,704 with an average share price of $55.79 per share and the total transaction amounting to $1,210,866.16.
  • On 5/5/2017 Vivian Lopez-Blanco, CFO, sold 7,778 with an average share price of $55.82 per share and the total transaction amounting to $434,167.96.
  • On 2/23/2017 Enrique Sosa, Director, sold 10,668 with an average share price of $69.65 per share and the total transaction amounting to $743,026.20.
  • On 2/17/2017 Vivian Lopez-Blanco, CFO, sold 15,164 with an average share price of $70.01 per share and the total transaction amounting to $1,061,631.64.



    Recent Trading for Mednax, Inc (NYSE:MD)
    Shares of Mednax, Inc closed the previous trading session at 50.65 down -5.84 -10.34% with 1,117,824 shares trading hands.